Greenland Mines Ltd. (NASDAQ: GRML) disclosed in a Form 4 filing that Chief Financial Officer Jeff LeBlanc purchased 1.4 million shares of the company’s common stock in open-market transactions. According to the filing, LeBlanc acquired the shares at a price of $0.1752 per share, increasing his direct beneficial ownership to 4,820,342 shares.
The filing states that LeBlanc purchased 626,472 shares on July 16, 2026, and an additional 773,528 shares on July 17, 2026. The transactions were reported in a filing with the U.S. Securities and Exchange Commission on July 17.
Insider purchases often signal confidence in a company’s future prospects. LeBlanc’s substantial acquisition suggests that he believes in Greenland Mines’ strategic direction and potential for growth. The purchase comes as the company advances its dual operating divisions: mining and biotech.
Greenland Mines Ltd is a Nasdaq-listed company with two operating divisions: (1) Mining, focused on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland; and (2) Biotech, including Klotho’s KLTO‑202 primary indication for ALS. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure.
The mining division’s focus on rare earth elements, particularly neodymium and praseodymium, positions the company to meet growing demand for materials used in permanent magnets for electric vehicles and wind turbines. The biotech division’s KLTO-202 program targeting ALS represents a potential breakthrough in treating neurodegenerative diseases. By maintaining both divisions, Greenland Mines diversifies its risk while targeting high-growth sectors.
For investors, the CFO’s purchase may be seen as a strong vote of confidence. Insider buying is often monitored as an indicator of a company’s health and future performance. LeBlanc’s increased stake aligns his interests with shareholders, potentially signaling that the company’s current valuation is attractive relative to its prospects.
The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML.
